M. Kondo et al., SELECTIVE MATERNAL-ALLELE LOSS IN HUMAN LUNG CANCERS OF THE MATERNALLY EXPRESSED P57(KIP2) GENE AT 11P15.5, Oncogene, 12(6), 1996, pp. 1365-1368
Genomic imprinting at 11p15 is suggested to play a role in certain ped
iatric tumors such as Wilms' tumor, based on the findings of selective
maternal loss of this chromosomal region, Although the allele loss at
11p15 is also frequent in a number of cancers of adults including lun
g, breast, and bladder cancers, possible involvement of genomic imprin
ting in these tumors has not been investigated extensively, p57(KIP2),
a newly described member of the p21 cyclin-dependent kinase (CDK) inh
ibitor family which is thought to negatively regulate the cell cylce a
t the G(1) checkpoint, has been mapped to 11p15, In the present study,
we searched for somatic p57(KIP2) mutations in lung cancer, but faile
d to find such alterations, Interestingly, however, we found that the
p57(KIP2) gene is imprinted with maternal expression and that the mate
rnal alleles had been selectively lost in 11 of 13 (85%) lung cancer c
ases carrying 11p15 deletions, this being a significant bias (P=0.01),
These data provide the first evidence that genomic imprinting may pla
y a role in the oncogenesis of not only rare pediatric tumors but also
this common cancer of adults, suggesting that the imprinted p57(KIP2)
CDK inhibitor gene is a potential target for maternally biased 11p15
deletions.